Catherine Elliott

Catherine Elliott has a strong background in the healthcare and communications field. Catherine is currently working as a Senior Scientific Director - Patient Partnerships at Envision Pharma Group since June 2022. Prior to this, they held the role of Senior Scientific Director at the same company from April 2020 to June 2022. Before joining Envision Pharma Group, Catherine worked as a Scientific Director at Chameleon Communications International from December 2018 to April 2020. Catherine'sprevious experience also includes roles such as Scientific Director and Principal Writer at Ashfield, part of UDG Healthcare plc, and Senior Medical Writer at Adelphi Communications and KnowledgePoint360 Group. Catherine has strong writing and communication skills, and their expertise in the medical field makes their a valuable asset to any organization.

Catherine Elliott began their education in 2000 at the University of Leeds, where they pursued a Bachelor of Science (BSc) degree in Biology with History and Philosophy of Science. Catherine completed their undergraduate studies in 2003. In 2004, Catherine enrolled in the University of Chester to earn a Postgraduate Certificate in Education (PGCE), focusing their studies on Secondary Education and Teaching with a specialization in Science. Catherine successfully completed their teaching degree in 2005.